Topics:

Schizoaffective

Treating Comorbid Anxiety With Schizophrenia

Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia.

Related content:
Mini Quiz: Antipsychotic Metabolic Effects

Schizoaffective

Phenomenology in an Acute Care Setting

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.

This member of the DSM-5 Work Group for Psychotic Disorders describes the 8 dimensions used to define the presentation of psychosis—the biggest and most clinically important of the changes in the schizophrenia and other psychotic disorders section.

This week's news stories: intimate partner violence, gun control and mental illness, eating disorders, and more.

The Clinical Assessment Interview for Negative Symptoms (CAINS) is an effective tool in measuring negative symptoms in schizophrenia, according to a recent study.

DSM-5 presents psychiatry with a potential “reset button” for diagnostic reliability.

The new annual suicide rate of 12.0 per 100,000 people translates into 100.8 suicides per day and 1 suicide every 14.3 minutes. Here, you will find tools and tips to help identify patients at risk.

Pages

Subscribe to Schizoaffective on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.